The right tests,
not the most tests
Having been recognized as the best gastroenterology and GI surgery hospital in the nation by U.S. News & World Report every year since 1990, when the rankings were first established, we know the importance of laboratory testing in a patient's care. Our disease-specific tests are clinically reinforced, cost-effective, and patient care-driven.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
Mayo Clinic’s rank in the U.S. News and World Report list of top gastroenterology and GI surgery hospitals
tests in our gastroenterology
digestive disease specialists on staff — one of the largest such groups in the world
tests performed annually
Providing answers, not just results
Our integration with gastroenterology patient-care clinics allows us to provide the best possible services and testing for each unique case.
Access to Mayo Clinic expertise
When you partner with us, you extend your network to include some of the world's leading gastroenterology experts. Our clinicians, laboratorians, and genetic counselors are available for consultation seven days a week to provide interpretive expertise and support.
Monogenic inflammatory bowel disease testing
Monogenic inflammatory bowel disease (IBD) refers to a diverse spectrum of rare genetic disorders that present with intestinal inflammation. However, because monogenic and polygenic IBD can have indistinguishable endoscopic or histologic features, establishing an accurate diagnosis via traditional methods remains a challenge.
In this month's "Hot Topic," Melissa Snyder, Ph.D., co-director of the antibody immunology laboratory at Mayo Clinic, discusses celiac disease and the role of diagnostic testing algorithms.
Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ malabsorption panel can provide timelier diagnosis for children with chronic diarrhea or unexplained weight loss. The novel panel, which bundles four existing tests, requires just one stool sample.
In this test specific episode of the "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.
Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which have associations to thiopurine metabolization.
In this month's "Hot Topic," Alicia Algeciras, Ph.D., DABCC, and Joshua Bornhorst, Ph.D., DABCC, discuss Alzheimer's disease CSF biomarkers.